These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2906191)

  • 61. Expression of interferon-gamma receptors in normal and psoriatic skin.
    Scheynius A; Fransson J; Johansson C; Hammar H; Baker B; Fry L; Valdimarsson H
    J Invest Dermatol; 1992 Feb; 98(2):255-8. PubMed ID: 1531061
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The irritant effect of dithranol using capillary resistance measurement].
    Kemény L; Csató M; Nyirádi J; Gábor M; Dobozy A
    Z Hautkr; 1989 Jan; 64(1):34-40. PubMed ID: 2522697
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).
    Myśliwiec H; Myśliwiec P; Baran A; Flisiak I
    Adv Med Sci; 2016 Sep; 61(2):207-211. PubMed ID: 26895458
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
    Saraswat A; Agarwal R; Katare OP; Kaur I; Kumar B
    J Dermatolog Treat; 2007; 18(1):40-5. PubMed ID: 17365266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunohistochemical study on the pattern of 50 kd cytokeratin in psoriasis.
    Fedi AM; Lotti T; Meo AL; Rizzo A; Leoncini P
    Int J Dermatol; 1992 Jan; 31(1):30-2. PubMed ID: 1371106
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of dithranol and a 'synthetic tar' as anti-psoriatic treatments using the mouse tail test.
    Wrench R; Britten AZ
    Br J Dermatol; 1975 Jul; 93(1):75-8. PubMed ID: 1191531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dithranol treatment of psoriasis in dithranol-sensitive patients.
    Prins M; Swinkels OQ; Mommers JM; Gerritsen MJ; van der Valk PG
    Contact Dermatitis; 1999 Aug; 41(2):116-7. PubMed ID: 10445706
    [No Abstract]   [Full Text] [Related]  

  • 70. Ambulatory treatment of psoriasis with dithranol sticks--a novel paraffin formulation.
    Brandt H; Gordin A; Mustakallio KK
    Dermatologica; 1985; 171(6):459-62. PubMed ID: 3912226
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dithranol in an emulsifying oil base (bio-wash-oil) for the treatment of psoriasis of the scalp.
    Wulff-Woesten A; Ohlendorf D; Henz BM; Haas N
    Skin Pharmacol Physiol; 2004; 17(2):91-7. PubMed ID: 14976386
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis.
    Raychaudhuri SP; Jiang WY; Farber EM; Schall TJ; Ruff MR; Pert CB
    Acta Derm Venereol; 1999 Jan; 79(1):9-11. PubMed ID: 10086850
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.
    Gottlieb SL; Heftler NS; Gilleaudeau P; Johnson R; Vallat VP; Wolfe J; Gottlieb AB; Krueger JG
    J Am Acad Dermatol; 1995 Oct; 33(4):637-45. PubMed ID: 7545705
    [TBL] [Abstract][Full Text] [Related]  

  • 74. "Ditrawash"--a novel remover of dithranol (anthralin) for short contact therapy of psoriasis.
    Mustakallio KK
    Acta Derm Venereol Suppl (Stockh); 1989; 146():201-2. PubMed ID: 2609870
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
    Göransson A
    Acta Derm Venereol; 1987; 67(1):72-6. PubMed ID: 2436419
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nucleolar ultrastructure in psoriatic skin lesions.
    Karásek J; Janula J; Smetana K
    J Invest Dermatol; 1981 Oct; 77(4):369-72. PubMed ID: 6168711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy.
    Schaefer H; Farber EM; Goldberg L; Schalla W
    Br J Dermatol; 1980 May; 102(5):571-3. PubMed ID: 7387901
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ultrastructural changes in psoriatic epidermis following anthralin treatment.
    Wilborn WH; Montes LF
    J Cutan Pathol; 1974; 1(3):132-50. PubMed ID: 4377841
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of psoriasis with dithranol cream compared with dithranol paste.
    Young E
    Dermatologica; 1986; 173(6):285-7. PubMed ID: 3817239
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of the short-duration dithranol and Dithrocream therapy in the treatment of psoriasis.
    Fräki JE; Neittaanmäki H; Väätäinen N
    Dermatologica; 1985; 171(1):52-4. PubMed ID: 4029462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.